Quick Takeaways
- Gary S. Stetz has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $172,296.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Gary S. Stetz
- Location
- Bayonne, NJ
- Summary
- The estimated net worth of Gary S. Stetz is at least $172,296 dollars as of 18 Mar 2026. Gary S. Stetz is the Director of Tharimmune, Inc. and owns shares of Canton Strategic Holdings, Inc. (CNTN) stock worth about $172.3K.
- Signature
- /s/ Gary S. Stetz
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Gary S. Stetz and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Tharimmune, Inc. ($172,296).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Gary S. Stetz
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| CNTN | Tharimmune, Inc. | Director | $172,296 | 03 Nov 2025 | ||
| HEPA, CTRVP | Hepion Pharmaceuticals, Inc. | Chief Executive Officer, Director | 16 Mar 2026 |
Insider Transactions Reported by Gary S. Stetz:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.